| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/29/2005 | US6969520 Active immunization against clostridium difficile disease |
| 11/29/2005 | US6969519 Nucleotide sequences coding membrane protein for use in the treatment of autoimmune, rheumatoid disease, dibates, multiple sclerosis, Sjogren's syndome, glomerulonephritis and myasthenia gravis |
| 11/29/2005 | US6969518 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/29/2005 | US6969513 administering a live attenuated bacterial vector vaccine to a patient, wherein the vaccine containing an isolated cell comprising an expression vector, contains a nucleotide sequence encoding a restricted-copy-number origin of replication cassette |
| 11/29/2005 | CA2223960C Reconstituted collagen fiber segment compositions and methods of preparation thereof |
| 11/29/2005 | CA2146964C Particles having gelatin-aminodextran coatings of and processes for making same |
| 11/29/2005 | CA2118329C Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin e |
| 11/24/2005 | WO2005111225A1 O-linked glycoforms of polypeptides and method to manufacture them |
| 11/24/2005 | WO2005111221A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 11/24/2005 | WO2005111216A2 Methods for modifying plant characteristics |
| 11/24/2005 | WO2005111213A1 Target gene mimitin of myc |
| 11/24/2005 | WO2005111200A1 Novel strains of reoviruses and methods of uses thereof |
| 11/24/2005 | WO2005111199A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 11/24/2005 | WO2005111081A2 Immunoglobulin-like variable chain binding polypeptides and methods of use |
| 11/24/2005 | WO2005111079A2 Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41 |
| 11/24/2005 | WO2005111076A1 Nectin 4 (n4) as a marker for cancer prognosis |
| 11/24/2005 | WO2005111075A2 CRYSTAL STRUCTURE OF FACTOR VAi AND METHOD FOR IDENTIFYING BLOOD FACTOR Va MODULATORS |
| 11/24/2005 | WO2005111074A1 Modified coagulation factors with enhanced stability and their derivatives |
| 11/24/2005 | WO2005111073A2 Channel forming peptides |
| 11/24/2005 | WO2005111072A2 Notch-based fusion proteins and uses thereof |
| 11/24/2005 | WO2005111071A1 Complex containing protein with ligand binding capacity, and method of screening substance capable of binding to protein with ligand binding capacity |
| 11/24/2005 | WO2005111070A2 Mucin3 egf-like domains |
| 11/24/2005 | WO2005111068A2 A method for purifying and recovering silk proteins using magnetic affinity separation |
| 11/24/2005 | WO2005111067A1 A novel identified oncogene with kinase-domain (nok) |
| 11/24/2005 | WO2005111066A2 Polypeptides from non-typeable haemophilus influenzae |
| 11/24/2005 | WO2005111065A2 Epitope-enhancement of a human cd4 hiv epitope |
| 11/24/2005 | WO2005110497A1 Imaging of tumors and metastases using a gelatinase targeting peptide comprising the structure ctthwgftlc. |
| 11/24/2005 | WO2005110493A2 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress |
| 11/24/2005 | WO2005110492A2 Method of using adenoviral vectors to induce an immune response |
| 11/24/2005 | WO2005110479A2 Treatments for pancreatic cancer |
| 11/24/2005 | WO2005110464A2 Irx5 inhibition as treatment for hyperproliferative disorders |
| 11/24/2005 | WO2005110461A2 Leptin peptide antagonists |
| 11/24/2005 | WO2005110459A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | WO2005110457A2 Treatment of eating disorders and induction of lipolysis |
| 11/24/2005 | WO2005110456A2 T-cell death-inducing epitopes |
| 11/24/2005 | WO2005110454A2 Protective binding members of pyy for the treatment of metabolic disorders |
| 11/24/2005 | WO2005110425A1 Polymer-based sustained release device |
| 11/24/2005 | WO2005110408A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 11/24/2005 | WO2005110338A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | WO2005110056A2 Compositions comprising addl receptor syngap |
| 11/24/2005 | WO2005110015A2 Cross-linkable glycoproteins and methods of making the same |
| 11/24/2005 | WO2005110009A2 COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d |
| 11/24/2005 | WO2005090397A8 Hypha-specific cell wall proteins of candida |
| 11/24/2005 | WO2005087931A8 Modified oncolytic viruses |
| 11/24/2005 | WO2005087799A3 Mvl, an antiviral protein from a cyanobacterium |
| 11/24/2005 | WO2005080577A3 Method for modulating gibberellic acid-dependent processes in plants |
| 11/24/2005 | WO2005079844A3 Use for interleukin-33 (il33) and the il-33 receptor complex |
| 11/24/2005 | WO2005079267A3 Methods for protein production |
| 11/24/2005 | WO2005073383A3 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 11/24/2005 | WO2005070958A3 Lawsonia intracellularis subunit vaccines |
| 11/24/2005 | WO2005067965A3 Use of protein products for preventing and treating pancreatic diseases and/or obestiy and/or metabolic syndrome |
| 11/24/2005 | WO2005067709A3 Chimeric murine model comprising human hepatocytes user for screening compounds |
| 11/24/2005 | WO2005065239A3 Novel recombinant proteins with n-terminal free thiol |
| 11/24/2005 | WO2005061539A3 Treatment of viral infections |
| 11/24/2005 | WO2005058958A3 Novel glp-1 analogues linked to albumin-like agents |
| 11/24/2005 | WO2005058358A3 Use of agents derived from ceacam1 for the treatment of inflammatory diseases |
| 11/24/2005 | WO2005051999A3 Substance binding human igg fc receptor iib |
| 11/24/2005 | WO2005049852A3 Methods and compositions for inducing apoptosis |
| 11/24/2005 | WO2005047511A3 Bacterial expression of protease inhibitors and variants thereof |
| 11/24/2005 | WO2005047306A3 A prion-like form of cpeb and related compositions and methods |
| 11/24/2005 | WO2005046710A3 Tgf-beta binding and supported peptides |
| 11/24/2005 | WO2005046709A3 Tgf - beta binding and supported peptides |
| 11/24/2005 | WO2005044980A9 Zap protein and related compositions and methods |
| 11/24/2005 | WO2005037083A3 Mn/ca ix and cancer prognosis |
| 11/24/2005 | WO2005035564A3 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 11/24/2005 | WO2005033132A3 Igf binding proteins |
| 11/24/2005 | WO2005030145A3 Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors |
| 11/24/2005 | WO2005021574A3 Induction of antiviral neutralizing antibodies in humans and animals |
| 11/24/2005 | WO2005017131A3 Methods for the differentiation of human stem cells |
| 11/24/2005 | WO2003073836A3 A stress-responsive promoter from maize |
| 11/24/2005 | WO2002070652A3 Novel molecules of the card-related protein family and uses thereof |
| 11/24/2005 | US20050262598 Proton transporters and uses in plants |
| 11/24/2005 | US20050262596 Embryo preferred promoter and method of using same |
| 11/24/2005 | US20050262595 Promotion of somatic embryogenesis in plants by PGA37 gene expression |
| 11/24/2005 | US20050262589 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 11/24/2005 | US20050262587 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 11/24/2005 | US20050262586 Low temperature responsive nucleotide sequences and uses thereof |
| 11/24/2005 | US20050262585 Soybean FGAM synthase promoters useful in parasite control |
| 11/24/2005 | US20050262584 Master activators of pathogen responsive genes |
| 11/24/2005 | US20050262582 Promoter molecules for use in plants |
| 11/24/2005 | US20050262579 Novel clock gene promoter |
| 11/24/2005 | US20050262578 Non-human animal models of atherosclerosis and methods of use thereof |
| 11/24/2005 | US20050262577 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 11/24/2005 | US20050261489 Immune system disorders, cancer, viral diseases |
| 11/24/2005 | US20050261488 Novel human membrane protein and polynucleotides encoding the same |
| 11/24/2005 | US20050261487 Dna molecules encoding ligand-gated ion channels from drosophila melanogaster |
| 11/24/2005 | US20050261483 Genes encoding proteins with pesticidal activity |
| 11/24/2005 | US20050261479 Method for purifying and recovering silk proteins using magnetic affinity separation |
| 11/24/2005 | US20050261478 For activating T and/or B cells by aggregating three or more cell surface antigens; the activation signals may result in either immune enhancement or immunosuppression |
| 11/24/2005 | US20050261477 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 11/24/2005 | US20050261476 Peptides for chlamydophila pneumoniae vaccine and diagnosis |
| 11/24/2005 | US20050261475 Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| 11/24/2005 | US20050261473 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 11/24/2005 | US20050261425 Multiblock copolymers having improved mechanical properties |
| 11/24/2005 | US20050261265 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 11/24/2005 | US20050261234 GFAP-based gene therapy for treatment of retinal diseases |
| 11/24/2005 | US20050261229 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 11/24/2005 | US20050261227 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 11/24/2005 | US20050261224 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 11/24/2005 | US20050261220 Tumor treating combinations, compositions and methods |